For the quarter ending 2025-09-30, ZIVOW made $65,625 in revenue. -$1,033,056 in net income. Net profit margin of -1574.18%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total revenues | 65,625 | 53,400 | ||
| Product costs | 44,337 | 35,478 | ||
| Total cost of goods sold | 44,337 | 35,478 | ||
| Gross margin | 21,288 | 17,922 | ||
| General and administrative | 836,187 | 1,171,137 | ||
| Research and development | 203,444 | 479,657 | ||
| Total costs and expenses | 1,039,631 | 1,650,794 | ||
| Loss from operations | -1,018,343 | -1,632,872 | ||
| Interest expense | 12,959 | 7,360 | ||
| Amortization of debt discount | - | 0 | ||
| Other expense | 1,754 | 7,360 | ||
| Total other expense | -14,713 | - | ||
| Net loss | -1,033,056 | -1,640,232 | ||
| Basic and diluted loss per share | -0.27 | -0.43 | ||
| Weighted average basic and diluted shares outstanding | 3,817,172 | 3,810,065 | ||
Zivo Bioscience, Inc. (ZIVOW)
Zivo Bioscience, Inc. (ZIVOW)